When selecting an appropriate insulin regimen to optimally manage hyperglycemia in T2DM patients, it is best to choose one that is individual-specific (i.e., based on A1C value, fasting vs. prandial BG levels, age, body weight, presence of comorbidities, and at-home insulin dose prior to admission when applicable). This evidence concerns the gene INS and type 2 diabetes mellitus.